ITMN : Today I am going to go through a quick rundown of my opinion on Intermune&s Pirfenidone and whether or not the drug will get approved. I&ll be citing a lot of info from the FDA&s panel hearing (here). ...
We are seeing many news-related movers in today&s edition of the BioHealth Business Daily. ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), Adeona Pharmaceuticals, Inc. (AMEX: AEN), Dendreon Corporation (NASDAQ: DNDN), Exact Sciences Corp.
ITMN : Today I am going to go through a quick rundown of my opinion on Intermune&s Pirfenidone and whether or not the drug will get approved. I&ll be citing a lot of info from the FDA&s panel hearing (here). ...
ITMN : Today I am going to go through a quick rundown of my opinion on Intermune&s Pirfenidone and whether or not the drug will get approved. I&ll be citing a lot of info from the FDA&s panel hearing (here). ...
Intermune (ITMN) is halted, news pending. It&s probably related to Esbriet(R) (pirfenidone) for pulmonary fibrosis, which an FDA panel recommended approval of on Mar 9. A May 4 target date has been set under the PDUFA. ...
No comments:
Post a Comment